Testosterone subcutaneous - NovavaxAlternative Names: ANDRO-Ject
Latest Information Update: 28 Aug 2002
At a glance
- Originator Novavax
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Eye disorder therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Andropause
Most Recent Events
- 28 Aug 2002 Preclinical trials in Andropause in USA (SC)